BMI1 overexpression dramatically promoted drug efflux, enhanced viability and decreased apoptosis of bladder cancer cells upon chemotherapy with DDP or GEM, whereas BMI1 downregulation reversed this effect. The gene discussed is BMI1; the disease is urinary bladder carcinoma.